EuglenaEuglena Co., Ltd.2931東証プライム食料品FY ending Dec 2025, consolidated, J-GAAP
About 94% of Euglena's sales come from Health care Business, with Others Business and Biofuel Business making up much of the rest.
It lost about ¥8 for every ¥100 of sales at the operating level.
Revenue changed +233.3% from the prior year.
FY ending Sep 2020 → FY ending Dec 2022
FY ending Sep 2020 → FY ending Dec 2022
For every ¥100 Euglena sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第21期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第20期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第19期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第18期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第17期(令和2年10月1日-令和3年12月31日)
Extracted from XBRL: 51 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.